SignatureFD’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $845K | Buy |
4,608
+238
| +5% | +$43.9K | 0.01% | 442 |
|
|
2025
Q4 | $769K | Buy |
4,370
+28
| +0.6% | +$4.57K | 0.01% | 453 |
|
|
2025
Q3 | $608K | Sell |
4,342
-229
| -5% | -$31K | 0.01% | 525 |
|
|
2025
Q2 | $574K | Buy |
4,571
+1,874
| +69% | +$234K | 0.01% | 523 |
|
|
2025
Q1 | $369K | Buy |
2,697
+605
| +29% | +$86.5K | 0.01% | 640 |
|
|
2024
Q4 | $320K | Buy |
2,092
+71
| +4% | +$12K | 0.01% | 699 |
|
|
2024
Q3 | $392K | Sell |
2,021
-1,277
| -39% | -$267K | 0.01% | 596 |
|
|
2024
Q2 | $765K | Buy |
3,298
+1,310
| +66% | +$285K | 0.02% | 378 |
|
|
2024
Q1 | $429K | Sell |
1,988
-181
| -8% | -$42.4K | 0.01% | 558 |
|
|
2023
Q4 | $561K | Sell |
2,169
-37
| -2% | -$9.09K | 0.01% | 442 |
|
|
2023
Q3 | $567K | Sell |
2,206
-349
| -14% | -$93.3K | 0.01% | 404 |
|
|
2023
Q2 | $728K | Buy |
2,555
+162
| +7% | +$48.2K | 0.02% | 331 |
|
|
2023
Q1 | $665K | Sell |
2,393
-73
| -3% | -$20.2K | 0.02% | 340 |
|
|
2022
Q4 | $683K | Buy |
2,466
+733
| +42% | +$207K | 0.02% | 314 |
|
|
2022
Q3 | $463K | Sell |
1,733
-84
| -5% | -$17.8K | 0.02% | 398 |
|
|
2022
Q2 | $371K | Sell |
1,817
-64
| -3% | -$13.1K | 0.01% | 461 |
|
|
2022
Q1 | $396K | Sell |
1,881
-304
| -14% | -$66.1K | 0.01% | 481 |
|
|
2021
Q4 | $524K | Sell |
2,185
-299
| -12% | -$76.9K | 0.02% | 377 |
|
|
2021
Q3 | $703K | Buy |
2,484
+79
| +3% | +$25.9K | 0.02% | 266 |
|
|
2021
Q2 | $833K | Buy |
2,405
+256
| +12% | +$77.6K | 0.03% | 233 |
|
|
2021
Q1 | $601K | Buy |
2,149
+37
| +2% | +$9.98K | 0.03% | 263 |
|
|
2020
Q4 | $517K | Sell |
2,112
-1,465
| -41% | -$378K | 0.02% | 265 |
|
|
2020
Q3 | $1.01M | Buy |
3,577
+928
| +35% | +$259K | 0.05% | 127 |
|
|
2020
Q2 | $709K | Sell |
2,649
-100
| -4% | -$30.1K | 0.04% | 159 |
|
|
2020
Q1 | $870K | Buy |
2,749
+459
| +20% | +$139K | 0.08% | 111 |
|
|
2019
Q4 | $680K | Sell |
2,290
-179
| -7% | -$49.7K | 0.05% | 179 |
|
|
2019
Q3 | $575K | Buy |
2,469
+712
| +41% | +$166K | 0.05% | 172 |
|
|
2019
Q2 | $411K | Sell |
1,757
-355
| -17% | -$82K | 0.04% | 217 |
|
|
2019
Q1 | $499K | Sell |
2,112
-122
| -5% | -$38.4K | 0.04% | 173 |
|
|
2018
Q4 | $672K | Buy |
2,234
+180
| +9% | +$57.4K | 0.06% | 128 |
|
|
2018
Q3 | $726K | Buy |
2,054
+81
| +4% | +$27.9K | 0.07% | 137 |
|
|
2018
Q2 | $573K | Buy |
1,973
+476
| +32% | +$134K | 0.06% | 152 |
|
|
2018
Q1 | $410K | Buy |
1,497
+86
| +6% | +$26.7K | 0.05% | 175 |
|
|
2017
Q4 | $450K | Buy |
1,411
+102
| +8% | +$32.7K | 0.05% | 163 |
|
|
2017
Q3 | $410K | Buy |
1,309
+199
| +18% | +$58.9K | 0.05% | 157 |
|
|
2017
Q2 | $301K | Buy |
1,110
+13
| +1% | +$3.44K | 0.04% | 190 |
|
|
2017
Q1 | $300K | Buy |
1,097
+124
| +13% | +$35.1K | 0.04% | 199 |
|
|
2016
Q4 | $276K | Buy |
973
+8
| +0.8% | +$2.37K | 0.05% | 166 |
|
|
2016
Q3 | $302K | Buy |
965
+247
| +34% | +$73.2K | 0.04% | 162 |
|
|
2016
Q2 | $174K | Buy |
718
+492
| +218% | +$130K | 0.03% | 199 |
|
|
2016
Q1 | $59K | Buy |
226
+15
| +7% | +$3.96K | 0.01% | 388 |
|
|
2015
Q4 | $65K | Buy |
211
+90
| +74% | +$25.9K | 0.01% | 321 |
|
|
2015
Q3 | $35K | Buy |
121
+70
| +137% | +$23.1K | 0.01% | 414 |
|
|
2015
Q2 | $21K | Buy |
51
+28
| +122% | +$11.2K | ﹤0.01% | 458 |
|
|
2015
Q1 | $10K | Buy |
23
+2
| +10% | +$788 | ﹤0.01% | 527 |
|
|
2014
Q4 | $7K | Buy |
+21
| New | +$6.79K | ﹤0.01% | 536 |
|
|
2014
Q2 | – | Sell |
-14
| Closed | -$4K | – | 881 |
|
|
2014
Q1 | $4K | Sell |
14
-102
| -88% | -$32.4K | ﹤0.01% | 551 |
|
|
2013
Q4 | $32K | Hold |
116
| – | – | 0.01% | 277 |
|
|
2013
Q3 | $28K | Hold |
116
| – | – | 0.01% | 286 |
|
|
2013
Q2 | $25K | Buy |
+116
| New | +$24.8K | 0.01% | 239 |
|
Other funds holding BIIB
VCM
VPM
SignatureFD's BIIB Position: Q1 2026 in Review
SignatureFD increased its Biogen (BIIB) stake by 5.4% in Q1 2026, buying an estimated $43.9K and bringing the position to 4,608 shares worth $845K. The position accounts for 0.01% of the portfolio, ranked #442.
SignatureFD first reported a position in BIIB in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.01M in Q3 2020. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- SignatureFD held 4,608 shares of Biogen worth $845K as of Q1 2026.
- SignatureFD bought 238 Biogen shares in Q1 2026, an estimated $43.9K.
- Biogen made up 0.01% of SignatureFD's portfolio in Q1 2026, its #442 holding.
- SignatureFD first reported a position in Biogen in Q2 2013 and has held it in 50 quarters since.
- SignatureFD's Biogen position peaked at $1.01M in Q3 2020.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.